Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,454 transcripts · 1,641 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 231 of 288 · 3,454 calls

  • Titan International (TWI) Q4 2024 earnings call

    The call shifted from bottoming-cycle language to cautious recovery optimism, with Brazil leading and Titan expecting early orders before OEM sell-through.

    Feb 27, 2025Positive0.65
  • Thryv Holdings (THRY) Q4 2024 earnings call

    Thryv framed Keap as accelerating its SaaS transition, with near-term integration execution supporting longer-term cross-sell and ARPU expansion.

    Feb 27, 2025Confident0.82
  • Donaldson (DCI) Q2 2025 earnings call

    Management framed the quarter as resilient execution: weaker markets were offset by share gains, cost discipline, and stronger aerospace and defense delivery.

    Feb 27, 2025Positive0.55
  • Luxfer Holdings (LXFR) Q4 2024 earnings call

    Management framed 2024 as a year of margin, cash-generation and portfolio progress, while warning that 2025 starts with clean-energy and order-timing headwinds.

    Feb 26, 2025Mildly positive0.35
  • Dole (DOLE) Q4 2024 earnings call

    Management framed 2024 as a record year, while positioning 2025 as slower initially but fundamentally healthy despite temporary disruptions and uncertainty.

    Feb 26, 2025Positive0.62
  • SES AI (SES) Q4 2024 earnings call

    Management framed SES AI’s shift from EV battery development toward an AI-led, capital-light model spanning materials, software, cells and adjacent markets.

    Feb 25, 2025Positive0.65
  • VTEX (VTEX) Q4 2024 earnings call

    Management characterized the miss as temporary, with Brazil softness and FX offsetting strong enterprise wins, margin expansion, and product expansion.

    Feb 25, 2025Positive0.62
  • Expro (XPRO) Q4 2024 earnings call

    Management framed 2025 as cautious but resilient, with efficiency actions, international exposure and technology supporting margins despite uneven markets.

    Feb 25, 2025Positive0.62
  • Orthofix Medical (OFIX) Q4 2024 earnings call

    Management framed 2025 as a cleaner, more focused growth year, with M6 exiting and 7D, innovation, and margin expansion carrying momentum.

    Feb 25, 2025Confident0.82
  • Henry Schein (HSIC) Q4 2024 earnings call

    Management framed 2025 as a reset year, with subdued markets and investments delaying leverage while restructuring and a new operating model support longer-term growth.

    Feb 25, 2025Mildly positive0.35
  • Hawaiian Electric Industries (HE) Q4 2024 earnings call

    Management framed HEI as financially stabilized, strategically simplified and moving toward settlement finalization and investment-grade credit ratings.

    Feb 21, 2025Mildly positive0.35
  • Emera (EMA) Q4 2024 earnings call

    Management framed 2025 as front-loaded growth, supported by foreign exchange, rate-base expansion, and balance-sheet repair, while emphasizing disciplined capital allocation.

    Feb 21, 2025Confident0.82

Companies covered

1,641 companies

157 more under A